AstraZeneca vaccine booster shot efficient in opposition to Omicron: Oxford lab research


A 3-dose course of AstraZeneca’s COVID-19 vaccine is efficient in opposition to the Omicron coronavirus variant, the pharmaceutical firm mentioned on Thursday, citing information from an Oxford College lab research.

The research, but to be revealed in a peer-reviewed medical journal, confirmed antibody ranges in opposition to Omicron after the booster shot have been larger than antibodies in individuals who had been contaminated with and recovered naturally from COVID-19.

After a three-dose course of the vaccine, neutralising ranges in opposition to Omicron have been just like these in opposition to the virus’s

variant after two doses, the corporate added.

The Anglo-Swedish drugmaker mentioned researchers at Oxford College who carried out the research have been impartial from those that labored on the vaccine, Vaxzevria, with AstraZeneca.

Source link

HostGator Web Hosting


Please enter your comment!
Please enter your name here